| 标题 |
Efficacy and Safety of Firsekibart in Patients With Acute Gout Unsuitable for Standard Therapy: 48-Weeks Results From an Open-Label Extension of a Randomized Phase 3 Trial
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Zhu Z, Xue Y, Chu T,et al. Efficacy and Safety of Firsekibart in Patients With Acute Gout Unsuitable for Standard Therapy: 48-Weeks Results From an Open-Label Extension of a Randomized Phase 3 Trial. Advances in therapy.2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
馨馨的科科
Nole
无极微光
cdercder
xing_xing
huang
潇洒的惋清
学术文献互助
MozzieMiao
mLI
XX
菜菜菜
狂野紫丝
DOC_XIONG
Dean
apricity
aaaa
挖掘机
立志干到博士退休
殷勤的紫槐
皖公网安备34019202002308
